XTL Biopharmaceuticals logo
XTL Biopharmaceuticals
XTLB | NASDAQ
Chart Builder DCF Calculator
$1.54
-$0.06 (-3.75%)
At close: Nov 16, 2026, 4:00 PM ET
$1.56
+$0.02 (+1.30%)
After-hours: Nov 16, 2026, 7:30 PM ET

XTL Biopharmaceuticals Income Statement

Income statement explained
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
– 451K – – – –
– 448K – 1K 1K 1K
– 3K – -1K -1K -1K
-1.69M -2.17M -765K -880K -1.03M -948K
60K 34K 41K 36K 8K 33K
-759K -1.16M -1.78M -1.35M 435K -2.95M
-6.97M -1.03M -1.78K -1.35M 435K -782K
1.13M 2.05M 734K 850K 1M 910K
28K 98K 31K 30K 30K 38K
531K 31K – – – –
1.69M 2.18M 765K 880K 1.03M 948K
7K 86K 4K 11K 21K 17K
– 178K – – – –
1.69M 2.62M 765K 880K 1.03M 948K
– -130K – – – –
420.65K 420.65K 340.57K 340.57K 332.5K 321.38K
440.1K 440.1K 340.57K 340.57K 384.72K 321.38K
-17 -2.40 -30 -4 1.28 -9.12
-16 -2.40 -30 -4 1.12 -9.12
-752K -930K -764K -879K -1.03M -947K
-752K -1.13M -765K -880K -1.03M -948K
– 199K 1K 1K 1K 1K

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.